SummaryQuestionnaires were distributed to all 213 consultant anaesthetists in the North-West region of the UK with a response rate of 68%. These questionnaires were designed to assess the hygienic precautions taken to reduce the potential for transmission of infectious agents to and from the patients under their care. Face masks and gloves were always used by 35.2% and 14.5%, respectively, while only 36.4% washed their hands between cases. Most respondents have changed their practice since the recognition of HIV transmission (74.8%) and hepatitis B and C (69.8%). A high proportion of anaesthetists continue to administer anaesthesia despite suffering from respiratory (94%), gastrointestinal (42.9%) or herpes simplex (32.6%) infections. The anaesthetic breathing system was changed at the end of each day or following a high-risk case by 33.3% of the respondents, while just over 25% changed it following a known infected case. Bacterial filters were used by 17% and changed after each case by 7.2%. On a scale of 0-10 (10 ¼ significant) anaesthetists rated their potential for transmitting or contributing to patient infection as a median of 3 (interquartile range: 2-6). The results of this study show that, although anaesthetists are well aware of proper hygienic practices, their performance falls short of accepted recommendations.

SummaryNinety patients, divided into three groups of 30, were investigated to determine the incidence of gastric regurgitation during general anaesthesia administered via the laryngeal mask airway in the supine, Trendelenburg and lithotomy positions. Fifteen minutes before induction of anaesthesia eachpatient swallowed a 75 mg methylene blue capsule. At the endof surgery, the LMA and the oropharynx were inspected for bluish discoloration which was considered to be a sign of gastric regurgitation. No blue dye was detected in the supine group but it was observed in one patient in each of the other two groups.

We have studied in seven healthy conscious volunteers the correlation between the electromyographic (EMG) and clinical criteria used to identify adequate recovery from sub-paralysing doses of pipecuronium. Pipecuronium (mean dose 1.88 (range 0.92-3.16) mg) was administered to reach a T4/T1 ratio of 0.5; full recovery to 1.0 was produced in a mean time of 25.3 (14-39) min. During recovery from neuromuscular block, we measured tidal volume, forced vital capacity (FVC), forced expiratory volume in 1 s (FEV1) negative inspiratory pressure (NIP), peak expiratory flow rate (PEFR), mid-expiratory flow rate (MEFR) and 5-s head lift. The assessments were started when the train-of-four (TOF) ratio reached 0.5 +/- 0.001 and repeated at each 0.1 +/- 0.001 increase up to a ratio of 1.0. All volunteers showed ptosis and diplopia after the first dose and difficulty in swallowing with subsequent doses. They also experienced a pleasant, relaxing sedative sensation. All could sustain head lift for 5 s at a TOF ratio of 0.5 and higher, except for one subject who could not lift his head only at a ratio of 0.5. There was a statistically significant decrease in FVC, FEV1 and PEFR with a nonsignificant decrease in other pulmonary measurements, except for NIP which only decreased significantly at a ratio of 0.5. These changes are probably of no clinical importance. All the measured respiratory variables returned to control values at a TOF ratio of 0.9.

No abstract

No abstract